Related Experiment Video
Updated: Mar 14, 2026

Transcranial Pulse Stimulation for Alzheimer's Patients
Published on: April 4, 2025
Towards Personalized Intervention for Alzheimer's Disease
Xing Peng1, Peiqi Xing1, Xiuhui Li1
1CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China; Cunji Medical School, University of Chinese Academy of Sciences, Beijing 100049, China.
Alzheimer's disease (AD) is complex due to patient heterogeneity. Tailored interventions require detailed demographic and in-depth data for effective patient stratification and future treatment strategies.
Area of Science:
- Neuroscience
- Genetics
- Biomarkers
Background:
- Alzheimer's disease (AD) presents a significant global health challenge.
- Disease etiology is highly heterogeneous, involving complex and divergent pathways.
- Current intervention strategies lack personalization due to this heterogeneity.
Purpose of the Study:
- To highlight the need for patient stratification in Alzheimer's disease research.
- To outline the types of data required for effective patient subgrouping.
- To emphasize the importance of personalized approaches for future AD interventions.
Main Methods:
- Collecting demographic data including APOE genotype, age, gender, education, lifestyle, and medical history.
- Gathering in-depth information through genome sequencing, brain imaging, and peripheral biomarkers.
- Utilizing functional assays on patient-derived induced pluripotent stem cells (iPSCs) for neuronal analysis.
Main Results:
- Patient stratification is crucial for developing effective Alzheimer's disease interventions.
- A combination of demographic and deep biological data is necessary for accurate subgrouping.
- Understanding disease mechanisms and diversifying drug development strategies are key.
Conclusions:
- Tailored intervention strategies are essential for subgroups of Alzheimer's disease patients.
- Comprehensive data collection and analysis will facilitate personalized medicine approaches.
- Future progress in Alzheimer's disease treatment hinges on addressing its inherent heterogeneity.
More Related Videos
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
06:46Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
Published on: August 4, 2018
Related Concept Videos
Alzheimer's Disease: Treatment
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Dementia
The progression of dementia is generally gradual....
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...